Subscribe to
this category


A total of 17 posts are filed under Strategy
Orchard Expands in Bay Area with Addition of Gene Therapy Facility
Rare Daily Staff Gene therapy developer Orchard Therapeutics said it has opened a second facility for technical operations in Menlo Park,… Continue Reading
Shire Names Bayer’s Andreas Busch as Head of R&D, CSO
  Rare Daily Staff Rare disease giant Shire named Andreas Busch, head of drug discovery and a member of the executive committee for the… Continue Reading
Tremeau Embraces Vioxx as Pain Treatment for Rare Diseases
Rare Daily Staff Tremeau Pharmaceuticals is seeking to bring Vioxx back to the market as a pain treatment for hemophilic arthropathy, a rare… Continue Reading
Shire Names Thomas Dittrich as CFO and Director
Rare Daily Staff Rare disease drug company Shire said it named Thomas Dittrich as its CFO and as a member of its board of directors. He… Continue Reading
Paying for Value
The drug industry long justified the pricing of its products on the basis of the high cost of R&D and the need for successes to offset the… Continue Reading
Translate Bio Names Barbier CMO
Rare Daily Staff RNA therapeutics developer Translate Bio said it named Ann Barbier, a biopharmaceutical veteran with deep experience in… Continue Reading
ATyr CEO Steps Down, CMO Takes Helm
Rare Daily Staff aTyr Pharma, a San Diego-based biotech focused on the discovery and development of therapies to treat severe, rare… Continue Reading